CD8A and myeloid sarcoma: The CD8+ Tcm response observed in MS-OCR patients following the first vaccination largely mimicked that of HCs except that more dynamic markers displayed an increased expression HC (Figure 5d and e), which was even more pronounced following the second vaccination in HC (Figure 5f and Figure 5—figure supplement 1e).